Renhe Pharmaceutical Co., Ltd. is a listed company listed on the Shenzhen Stock Exchange，The company's stock code is 000650，The predecessor of the company is Jiujiang Chemical Fiber Co., LTD，It was approved by people of Jiangxi Province in 1996， 18 November 1996,Approved by the China Securities Regulatory Commission (1996) No. 318，Companies officially listed on the Shenzhen Stock Exchange。In 2006, the company implemented major asset restructuring，Divest the original chemical fiber related assets，It also injected pharmaceutical assets，Through multiple rights issues, transfer, directional additional issues and other ways，Up to now，The company owns Jiangxi Renhe Pharmaceutical Co., LTD., Jiangxi Renhe Zhongfang Pharmaceutical Co., LTD., Jiangxi Renhe Pharmaceutical Co., LTD., Jiangxi Heli Pharmaceutical Co., LTD., Jiangxi Kangmei Pharmaceutical and Health Care Products Co., LTD., Jiangxi Yaodurenhe Pharmaceutical Co., LTD., Jiangxi Tonggu Renhe Pharmaceutical Co., LTD., Jiangxi Xianxin Pharmaceutical Co., LTD., Jiangxi Ji 'an Sanli Pharmaceutical Co., LTD.Jiangxi Renhe Pharmaceutical Plastic Products Co., LTD., Jiangxi Pharmaceutical Co., LTD., Jiangxi Pharmaceutical City Zhangshu Pharmaceutical Co., Ltd. and other subsidiaries of modern pharmaceutical production and management enterprises。

The company's main business: production and sales of Chinese and Western medicines, apis and health-related products, including oral solid preparation, oral liquid preparation, large volume injection, small volume injection, topical lotion, liniment, suppository, ointment and other dosage forms and health-related products。The company's main products: Renhe Kerik, Yucadan series, Fuyanjie series, Dahuoluo capsule, shining eye drops, Qinghuo capsule, Zhengstomach capsule, etc。